Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengping Liu

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Methods & Clinical Development|March 3, 2025
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primatesMengping Liu, Erica Cook, Yanshan Dai, et al.
Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymeraseJulie A Lemm, Mengping Liu, Robert G Gentles, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymeraseRobert G Gentles, Steven Sheriff, Brett R Beno, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymeraseMin Ding, Feng He, Thomas W Hudyma, et al.
Nature|November 5, 2015
Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5AJin-Hua Sun, Donald R O'Boyle, Robert A Fridell, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
HCV NS5A replication complex inhibitors. Part 2: investigation of stilbene prolinamidesDenis R St Laurent, Makonen Belema, Min Gao, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2017
Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymeraseBarbara Zhizhen Zheng, Stanley V D'Andrea, Umesh Hanumegowda, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesOmar D Lopez, Van N Nguyen, Denis R St Laurent, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Methods & Clinical Development|March 3, 2025
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primatesMengping Liu, Erica Cook, Yanshan Dai, et al.
Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2014
Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymeraseJulie A Lemm, Mengping Liu, Robert G Gentles, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymeraseRobert G Gentles, Steven Sheriff, Brett R Beno, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymeraseMin Ding, Feng He, Thomas W Hudyma, et al.
Nature|November 5, 2015
Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5AJin-Hua Sun, Donald R O'Boyle, Robert A Fridell, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
HCV NS5A replication complex inhibitors. Part 2: investigation of stilbene prolinamidesDenis R St Laurent, Makonen Belema, Min Gao, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2017
Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymeraseBarbara Zhizhen Zheng, Stanley V D'Andrea, Umesh Hanumegowda, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesOmar D Lopez, Van N Nguyen, Denis R St Laurent, et al.
Pageof 5